Medicon Valley Alliance and Clario would like to welcome you to a Good Morning Meeting 7th of May 2025. Discover an informative seminar delving into the transformative role of artificial intelligence (AI) in clinical trials: where the industry is currently at, common misconceptions in leveraging AI, proactively tackling the potential for bias and navigating the […]

Medicon Valley Alliance and PCI would like to welcome you to a Good Morning Meeting 20th of May 2025. The pharmaceutical industry is undergoing a rapid transformation driven by scientific breakthroughs, evolving regulatory landscapes, and the demand for more targeted, patient-centric therapies. Innovation in the Pharmaceutical World will spotlight key advancements shaping the future of […]

Medicon Valley Alliance and Servier are delighted to invite you to Servier’s 2025 R&D Partnering Day in The Nordics Servier is one of the leading French pharmaceutical companies. We have a long-standing commitment to external collaborations, particularly in oncology, neurology and technology platforms, to bring innovative medicines to patients. With our presence in Denmark through […]

Medicon Valley Alliance and Inotiv would like to welcome you to a Good Morning Meeting on the 27th of May 2025. Parkinson’s disease (PD) is a progressive neurodegenerative disorder affecting over 10 million people worldwide. It is primarily characterized by the selective loss of dopaminergic neurons in the substantia nigra and subsequent disruption of basal […]

Medicon Valley Alliance and Smithers would like to welcome you to a Good Morning Meeting 4th of June 2025. The assessment of extractables and leachables (E&L) on pharmaceutical products, medical devices, delivery systems, and processing equipment have continued to evolve. This aligns with the expanding exposure of polymeric materials to patients, resulting in the path […]

Medicon Valley Alliance and Pharmaron would like to welcome you to a Good Morning Meeting 11th of June 2025. Imagine trying to discover and develop a medicine without knowledge of its metabolism and pharmacokinetic properties, or being able to contextualise drug behaviour across species using a range of computational, in vitro and in vivo approaches? […]

The first Good Morning Ambassador Meeting in 2013 will focus on eHealth solutions and status of telemedicine in two highly interesting countries, Japan and South Korea. Note that this event will be held in Sweden 25 February and in Denmark 26 February!

The first Good Morning Ambassador Meeting in 2013 will focus on eHealth solutions and status of telemedicine in two highly interesting countries, Japan and South Korea. Note that this event will be held in Sweden 25 February and in Denmark 26 February!

As the size and complexity of large scientific datasets increases, life sciences teams from industry and academic are using cloud computing to deliver results more quickly, at larger scale and more cost effectively. Medicon Valley Alliance in collaboration with Amazon Web Services is excited to invite you to a morning of lively discussion…

Patents are challenged during examination, opposition, and invalidity proceedings and are subjected to scrutiny during due diligence. Patent authorities and competitors try to break through the defenses. Licensees use any weakness in the patents to lower the price. Only the good patents survive. Learn from the patent experts of Høiberg how to distinguish good from […]

Patents are challenged during examination, opposition, and invalidity proceedings and are subjected to scrutiny during due diligence. Patent authorities and competitors try to break through the defenses. Licensees use any weakness in the patents to lower the price. Only the good patents survive. Learn from the patent experts of Høiberg how to distinguish good from […]

IPR rules and issues in relation to the Korean market – is patenting different in Korea, compared to Europe and USA? Yes – there are differences in legislation and practices in addition to cultural differences, which together may lead to a different outcome in the patent application process in Korea compared to Europe or America. […]